TeleDaaS Unveils Cutting-edge Cancer Treatment Breakthrough at RSNA 2023
TeleDaaS, a Dosimetry-as-a-Service pioneer, unveils its breakthrough platform at #RSNA2023. Specializing in precision dosimetry for CROs and pharmaceuticals, TeleDaaS integrates seamlessly with imaging workflows to advance cancer treatment research. Led by Dr. Mark Crockett,…
Continue Reading